• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾病患者的血管发育异常:危险因素分析及此类患者的管理方法

Angiodysplasia in Renal Disease Patients: Analysis of Risk Factors and Approach to Manage Such Patients.

作者信息

Verma Sadhika, Attallah Marline A, Jarrin Jara Maria Daniela, Gautam Avneesh S, Khan Safeera

机构信息

Internal Medicine, California Institute of Behavorial Neurosciences and Psychology, Fairfield, USA.

Internal Medicine, California Institute of Behavorial Neurosciences and Psychology, Fairfiled, USA.

出版信息

Cureus. 2020 Aug 16;12(8):e9784. doi: 10.7759/cureus.9784.

DOI:10.7759/cureus.9784
PMID:32953300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7491692/
Abstract

Gastrointestinal bleeding due to angiodysplasia is a common problem in patients with renal insufficiency. There are several theories to explain the increased occurrence of these lesions in this specific group of patients, including various metabolic factors and existence of comorbidities. Advancements made in diagnostic measures have helped route the approach in patients with different risk factors and have also helped solve the dual purpose involving therapeutic intervention with endoscopy. We conducted a thorough literature search on PubMed to extract relevant data. A total of 29 articles were chosen after applying the inclusion and exclusion criteria. Although the clinical presentations may vary in this cohort of patients, and bleeding is known to stop spontaneously, a conservative approach may not be enough. Endoscopic treatment, use of hormones like estrogen, octreotide, and vasopressin, arterial embolization, and lastly surgery are valuable therapeutic tools.

摘要

血管发育异常所致的胃肠道出血是肾功能不全患者的常见问题。有几种理论来解释这些病变在这一特定患者群体中发生率增加的原因,包括各种代谢因素和合并症的存在。诊断措施的进步有助于针对不同风险因素的患者制定治疗方案,也有助于解决涉及内镜治疗干预的双重目的。我们在PubMed上进行了全面的文献检索以提取相关数据。应用纳入和排除标准后共选择了29篇文章。尽管该患者群体的临床表现可能有所不同,且已知出血可自发停止,但保守治疗方法可能并不足够。内镜治疗、使用雌激素、奥曲肽和血管加压素等激素、动脉栓塞以及最后的手术都是有价值的治疗手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4912/7491692/dfb510d7153c/cureus-0012-00000009784-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4912/7491692/09c7d5b7cd71/cureus-0012-00000009784-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4912/7491692/dfb510d7153c/cureus-0012-00000009784-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4912/7491692/09c7d5b7cd71/cureus-0012-00000009784-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4912/7491692/dfb510d7153c/cureus-0012-00000009784-i02.jpg

相似文献

1
Angiodysplasia in Renal Disease Patients: Analysis of Risk Factors and Approach to Manage Such Patients.肾病患者的血管发育异常:危险因素分析及此类患者的管理方法
Cureus. 2020 Aug 16;12(8):e9784. doi: 10.7759/cureus.9784.
2
Angiodysplastic lesions as a cause of colonic bleeding in patients with chronic renal disease: is there an association?血管发育异常性病变作为慢性肾病患者结肠出血的一个原因:存在关联吗?
Saudi J Kidney Dis Transpl. 2012 Sep;23(5):925-8. doi: 10.4103/1319-2442.100858.
3
Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract.长效奥曲肽在控制胃肠道血管发育异常再出血方面有效。
Dig Liver Dis. 2001 May;33(4):330-4. doi: 10.1016/s1590-8658(01)80087-6.
4
[Octreotide in the treatment of angiodysplasia in patients with advanced chronic renal failure].[奥曲肽治疗晚期慢性肾衰竭患者血管发育异常]
Nefrologia. 2005;25(3):332-5.
5
Medical and endoscopic therapies for angiodysplasia and gastric antral vascular ectasia: a systematic review.血管发育不良和胃窦血管扩张的医学和内镜治疗:系统评价。
Clin Gastroenterol Hepatol. 2014 Apr;12(4):571-82. doi: 10.1016/j.cgh.2013.08.038. Epub 2013 Sep 5.
6
Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases.长效释放奥曲肽作为“挽救”疗法控制血管发育异常出血:98例回顾性研究
Dig Liver Dis. 2014 Aug;46(8):688-94. doi: 10.1016/j.dld.2014.04.011. Epub 2014 Jun 2.
7
Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia.奥曲肽预防胃肠道血管发育异常所致反复出血的长期疗效
Am J Gastroenterol. 2007 Feb;102(2):254-60. doi: 10.1111/j.1572-0241.2007.01053.x.
8
Gastrointestinal angiodysplasia.胃肠道血管发育异常
J Assoc Acad Minor Phys. 1997;8(1):16-9.
9
Role of Octreotide in Pediatric Gastrointestinal Bleeding Secondary to Angiodysplasia in Children With Right Heart Failure.奥曲肽在右心衰竭患儿血管发育异常继发小儿胃肠道出血中的作用
J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):e41-e44. doi: 10.1097/MPG.0000000000001659.
10
Estrogen-progesterone therapy for recurrent gastrointestinal bleeding secondary to gastrointestinal angiodysplasia.
Am J Gastroenterol. 1988 May;83(5):556-8.

引用本文的文献

1
Prevalence of hypertension and cardiovascular risk in patients with gastrointestinal angiodysplasia: the role of aortic stiffness and non-dipper blood pressure patterns; predictive value of novel inflammatory biomarkers.胃肠道血管发育异常患者的高血压患病率及心血管风险:主动脉僵硬度和非勺型血压模式的作用;新型炎症生物标志物的预测价值。
Front Cardiovasc Med. 2025 Aug 26;12:1561853. doi: 10.3389/fcvm.2025.1561853. eCollection 2025.
2
Small Bowel Bleeding Due to Vascular Lesions: Pathogenesis and Management.血管病变所致小肠出血:发病机制与处理
Curr Gastroenterol Rep. 2025 Jun 7;27(1):37. doi: 10.1007/s11894-025-00989-1.
3

本文引用的文献

1
Hemodialysis Increases the Risk of Lower Gastrointestinal Bleeding and Angiodysplasia Bleeding: A Nationwide Population Study.血液透析增加下消化道出血和血管发育异常出血的风险:一项全国性人群研究。
Gastroenterol Res Pract. 2020 Mar 3;2020:7206171. doi: 10.1155/2020/7206171. eCollection 2020.
2
Diagnostic and therapeutic considerations for obscure gastrointestinal bleeding in patients with chronic kidney disease.慢性肾脏病患者隐匿性胃肠道出血的诊断与治疗考量
Ann Gastroenterol. 2019 Mar-Apr;32(2):113-123. doi: 10.20524/aog.2018.0341. Epub 2018 Dec 20.
3
Gastrointestinal lesions in chronic kidney disease patients with anaemia.
Gastrointestinal disease in end-stage renal disease.
终末期肾病中的胃肠疾病
World J Nephrol. 2025 Mar 25;14(1):101917. doi: 10.5527/wjn.v14.i1.101917.
4
Diagnostic evaluation and assessment of anemia in a patient with chronic kidney disease and gastrointestinal angioectasias undergoing hemodialysis.对一名患有慢性肾脏病且伴有胃肠道血管扩张并正在接受血液透析的患者进行贫血的诊断评估。
Clin Case Rep. 2022 Jul 11;10(7):e6027. doi: 10.1002/ccr3.6027. eCollection 2022 Jul.
慢性肾脏病贫血患者的胃肠道病变
Nefrologia (Engl Ed). 2019 Jan-Feb;39(1):50-57. doi: 10.1016/j.nefro.2018.05.010. Epub 2018 Aug 25.
4
Colonic Mucosal Ulceration and Gastrointestinal Bleeding Associated with Sevelamer Crystal Deposition in a Patient with End Stage Renal Disease.终末期肾病患者中与司维拉姆晶体沉积相关的结肠黏膜溃疡和胃肠道出血
Case Rep Nephrol. 2018 Feb 28;2018:4708068. doi: 10.1155/2018/4708068. eCollection 2018.
5
Nonisolated Small Bowel Gastrointestinal Angiodysplasias are Associated With Higher Rebleeding Rates When Compared With Isolated Small Bowel Gastrointestinal Angiodysplasia on Video Capsule Endoscopy.与视频胶囊内镜检查发现的孤立性小肠胃肠道血管发育异常相比,非孤立性小肠胃肠道血管发育异常与更高的再出血率相关。
J Clin Gastroenterol. 2018 Sep;52(8):726-733. doi: 10.1097/MCG.0000000000000836.
6
Role of computed tomography angiography on the management of overt obscure gastrointestinal bleeding.计算机断层血管造影在显性不明原因胃肠道出血管理中的作用
PLoS One. 2017 Mar 1;12(3):e0172754. doi: 10.1371/journal.pone.0172754. eCollection 2017.
7
Hemodialysis Switch Improved Colonic Angiodysplasia in a Peritoneal Dialysis Patient.血液透析转换改善了一名腹膜透析患者的结肠血管发育异常。
Perit Dial Int. 2016 Sep 10;36(5):578-9. doi: 10.3747/pdi.2015.00289.
8
Gastrointestinal bleeding due to angiodysplasia in patients on hemodialysis: A single-center study.血液透析患者血管发育异常所致胃肠道出血:一项单中心研究。
Saudi J Kidney Dis Transpl. 2016 Jul-Aug;27(4):748-51. doi: 10.4103/1319-2442.185237.
9
Analysis of risk factor and clinical characteristics of angiodysplasia presenting as upper gastrointestinal bleeding.以消化道出血为表现的血管发育异常的危险因素及临床特征分析
Korean J Intern Med. 2016 Jul;31(4):669-77. doi: 10.3904/kjim.2015.087. Epub 2016 Jan 29.
10
Endoscopic radiofrequency ablation for APC refractory gastric antral vascular ectasia using the HALO90 system in a kidney transplant candidate.在一名肾移植候选者中使用HALO90系统对APC难治性胃窦血管扩张症进行内镜下射频消融术。
Rev Esp Enferm Dig. 2015 May;107(5):307-8.